Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Breast Cancer 2022

03 - 05 May 2022

Berlin, Germany

ESMO-Breast-Cancer-2022-1000x1000-No-Bubbles

Resources from ESMO Breast Cancer 2022 are available according to the presenters' agreement to release them.

Abstracts and ePosters are open access.
Slides and webcasts are reserved to registered delegates and ESMO Members.

The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

The ESMO Breast Cancer Congress is a multidisciplinary meeting with a global scope, involving top scientists. This annual meeting is designed for researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and patient's care.

Watch the webcasts from our industry partners satellite symposia

ESMO Members: Read the articles from our Congress Watch

All congress resources are published
Type an abstract number in the search, or use the filters to refine the list!

Hide
Filter by:

There are 398 resources available

Q&A and discussion

Presenter: All Speakers

Session: YOC boxing session

Resources:

Webcast

Introduction

Presenter: Valentina Guarneri

Session: ESMO Colloquium supported by Lilly - Optimising risk prediction, management and compliance for patients with early HR+ HER2- breast cancer: The start of a journey

Resources:

Slides

Webcast

Panelists

Session: YO Vesalius talk: The road to a successful career in breast oncology research

Resources:

Webcast

Q&A and discussion

Presenter: All Speakers

Session: ESMO Colloquium supported by Lilly - Optimising risk prediction, management and compliance for patients with early HR+ HER2- breast cancer: The start of a journey

Resources:

Webcast

Concluding remarks

Presenter: Thomas Bachelot

Session: ESMO Colloquium supported by Lilly - Optimising risk prediction, management and compliance for patients with early HR+ HER2- breast cancer: The start of a journey

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.